AF
COYA icon

Allworth Financial’s Coya Therapeutics COYA Stock Holding History

Allworth Financial’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.94K Hold
1,000
– – ﹤0.01% 4088
2025
Q4 		$5.8K Hold
1,000
– – ﹤0.01% 3619
2025
Q3 		$5.7K Hold
1,000
– – ﹤0.01% 3478
2025
Q2 		$5.75K Buy
+1,000
New +$5.79K ﹤0.01% 3189

Other funds holding COYA

DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Allworth Financial's COYA Position: Q1 2026 in Review

Allworth Financial held its Coya Therapeutics (COYA) position steady in Q1 2026 at 1,000 shares worth $3.94K. The position accounts for ﹤0.01% of the portfolio, ranked #4088.

Allworth Financial first reported a position in COYA in Q2 2025 and has held it in 4 quarters since. The position peaked at $5.8K in Q4 2025. 56 funds tracked by Wall St. Rank hold COYA as of Q1 2026.

  • Allworth Financial held 1,000 shares of Coya Therapeutics worth $3.94K as of Q1 2026.
  • Allworth Financial left its Coya Therapeutics share count unchanged in Q1 2026.
  • Coya Therapeutics made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #4088 holding.
  • Allworth Financial first reported a position in Coya Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • Allworth Financial's Coya Therapeutics position peaked at $5.8K in Q4 2025.
  • 56 funds tracked by Wall St. Rank held Coya Therapeutics as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.